Cargando…

The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events

The objective of this study was to assess the relationship between factor XI (FXI) deficiency and the risks of bleeding and cardiovascular (CV) events. We conducted a retrospective cohort study using data from Maccabi Healthcare Services (MHS). We identified adults with FXI deficiency (severe: <1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharman Moser, Sarah, Chodick, Gabriel, Ni, Yan G., Chalothorn, Dan, Wang, Ming-Dauh, Shuldiner, Alan R., Morton, Lori, Salomon, Ophira, Jalbert, Jessica J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197592/ https://www.ncbi.nlm.nih.gov/pubmed/34555861 http://dx.doi.org/10.1055/s-0041-1735971

Ejemplares similares

Cancer‐associated venous thromboembolism in Israel: Incidence, risk factors, treatment, and health care utilization in a population based cohort study
por: Sharman Moser, Sarah, et al.
Publicado: (2022)

ThromboprophylaXIs with Factor XI/XIa inhibitors for venous thromboembolism
por: Porres-Aguilar, Mateo
Publicado: (2023)

Longitudinal Evaluation of Health Plan Cost per Venous Thromboembolism or Bleed Event in Patients With a Prior Venous Thromboembolism Event During Hospitalization
por: Bullano, Michael F., et al.
Publicado: (2005)

Factor XI, a potential target for anticoagulation therapy for venous thromboembolism
por: Li, Tingting, et al.
Publicado: (2022)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism
por: Ferrazzini, Elisa, et al.
Publicado: (2022)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Bleeding risk assessment for venous thromboembolism prophylaxis
por: Chindamo, Maria Chiara, et al.
Publicado: (2021)

Factor XI Inhibition for the Prevention of Venous Thromboembolism: An Update on Current Evidence and Future perspectives
por: Poenou, Geraldine, et al.
Publicado: (2022)

Inhibition of Factor XI: A New Era in the Treatment of Venous Thromboembolism in Cancer Patients?
por: Poenou, Géraldine, et al.
Publicado: (2023)

Thromboembolic events, bleeding, and mortality in patients with cerebral venous thrombosis: a nationwide cohort study
por: Skajaa, Nils, et al.
Publicado: (2022)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
por: Muster, Viktoria, et al.
Publicado: (2021)

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
por: Hisada, Yohei, et al.
Publicado: (2023)

Using machine learning to predict venous thromboembolism and major bleeding events following total joint arthroplasty
por: Shohat, Noam, et al.
Publicado: (2023)

Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients
por: Wang, Lan, et al.
Publicado: (2022)

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence
por: Nopp, Stephan, et al.
Publicado: (2022)

Venous thromboembolism events among RA patients
por: Mansour, Ribhi, et al.
Publicado: (2019)

Healthcare Utilization and Prevalence of Symptoms in Women with Menopause: A Real-World Analysis
por: Sharman Moser, Sarah, et al.
Publicado: (2020)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis
por: Lovely, Jenna K., et al.
Publicado: (2020)

Associations between coagulation factor XII, coagulation factor XI, and stability of venous thromboembolism: A case-control study
por: Meng, Yan, et al.
Publicado: (2022)

Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
por: Glueck, Charles J., et al.
Publicado: (2018)

Venous thromboembolic events in glioblastoma patients: An epidemiological study
por: Eisele, Amanda, et al.
Publicado: (2022)

Recurrence rate of venous thromboembolic events in granulomatosis with polyangiitis
por: Nevares, Alana, et al.
Publicado: (2022)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Bleeding in women with venous thromboembolism during pregnancy: A systematic review of the literature
por: Simard, Camille, et al.
Publicado: (2022)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
por: Lin, Yu-Sheng, et al.
Publicado: (2021)

Management of venous thromboembolism in patients with cancer: role of dalteparin
por: Linkins, Lori-Ann
Publicado: (2008)

Possible $\Xi^{0}$ event
por: CERN. Geneva. Track Chambers Division (TC)
Publicado: (2021)

Predictive value of venous thromboembolism (VTE)‐BLEED to predict major bleeding and other adverse events in a practice‐based cohort of patients with VTE: results of the XALIA study
por: Klok, Frederikus A., et al.
Publicado: (2018)

Recurrent thromboembolism, bleeding, and mortality in Asian patients with venous thromboembolism receiving different oral anticoagulants: A nationwide analysis
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Protein S Deficiency and the Risk of Venous Thromboembolism in the Han Chinese Population
por: Wu, Yingying, et al.
Publicado: (2022)

Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency
por: Ramdass, Sheryl K., et al.
Publicado: (2017)

Venous thromboembolic events in isolated severe traumatic brain injury
por: Mohseni, Shahin, et al.
Publicado: (2012)

Venous thromboembolic events during warm autoimmune hemolytic anemia
por: Audia, Sylvain, et al.
Publicado: (2018)

Elevated risk of venous thromboembolic events in patients with inflammatory myopathies
por: Nowak, Michał, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hchk860nnh5jc2smqan9l2l3lt